Incannex Healthcare Ltd
ASX:IHL

Watchlist Manager
Incannex Healthcare Ltd Logo
Incannex Healthcare Ltd
ASX:IHL
Watchlist
Price: 0.041 AUD Market Closed
Market Cap: 43.3m AUD

Operating Margin
Incannex Healthcare Ltd

-1 451.3%
Current
-1 029%
Average
6%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-1 451.3%
=
Operating Profit
-20m
/
Revenue
1.4m

Operating Margin Across Competitors

Country Company Market Cap Operating
Margin
AU
Incannex Healthcare Ltd
ASX:IHL
43.3m AUD
-1 451%
US
Eli Lilly and Co
NYSE:LLY
1T USD
44%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
3%
US
Johnson & Johnson
NYSE:JNJ
496.6B USD
27%
CH
Roche Holding AG
SIX:ROG
259.2B CHF
34%
UK
AstraZeneca PLC
LSE:AZN
212B GBP
24%
CH
Novartis AG
SIX:NOVN
208.2B CHF
33%
US
Merck & Co Inc
NYSE:MRK
251.4B USD
38%
DK
Novo Nordisk A/S
CSE:NOVO B
1.4T DKK
42%
IE
Endo International PLC
LSE:0Y5F
209B USD
11%
US
Pfizer Inc
NYSE:PFE
143.2B USD
29%
No Stocks Found

Incannex Healthcare Ltd
Glance View

Market Cap
43.3m AUD
Industry
Pharmaceuticals

Incannex Healthcare Ltd. is a cannabinoid and psychedelic compound medicine development company. The company is headquartered in Melbourne, Victoria. The company went IPO on 2007-05-23. The company is a clinical stage pharmaceutical development company. The firm is engaged in developing medicinal cannabis pharmaceutical products and psychedelic medicine therapies. Its product candidate IHL-42X is developing a combination of acetazolamide and dronabinol to reduce the apnea hypopnea index (AHI), IHL-216A is a combination of isoflurane and CBD to prevent development of traumatic brain injury (TBI)/concussion, HL-675A comprises a combination of hydroxychloroquine and CBD in prevention and treatment of inflammatory lung conditions (ARDS, COPD, asthma, and bronchitis), rheumatoid arthritis and inflammatory bowel diseases and Psi-GAD is providing Psychedelic-assisted psychotherapy for Generalized Anxiety Disorder (GAD).

IHL Intrinsic Value
Not Available
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-1 451.3%
=
Operating Profit
-20m
/
Revenue
1.4m
What is the Operating Margin of Incannex Healthcare Ltd?

Based on Incannex Healthcare Ltd's most recent financial statements, the company has Operating Margin of -1 451.3%.

Back to Top